Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment
- 1 November 2002
- journal article
- review article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 134 (5) , 749-760
- https://doi.org/10.1016/s0002-9394(02)01699-9
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Systemic Adverse Effects of Ophthalmic β-BlockersAnnals of Pharmacotherapy, 2001
- Beta-adrenergic blocker mortality trials in congestive heart failureThe American Journal of Cardiology, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular HypertensionOphthalmology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or MorningOphthalmology, 1995
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975
- Comparison of the Effect of Propranolol, Lignocaine, and Other Drugs on Normal and Raised Intraocular Pressure in ManAmerican Journal of Ophthalmology, 1971